Simcor

Indicated For

primary hypercholesterolemia, mixed dyslipidemia, hypertriglyceridemia

About This Medication

# Abbott Patient Assistance Program Guide: How to Get Simcor at Low or No Cost ## Important Notice Simcor (niacin extended-release/simvastatin) has been discontinued by Abbott Laboratories. This guide provides historical information about Abbott's patient assistance program. If you currently take Simcor or a similar medication, contact your healthcare provider about alternative treatments that may be available through current patient assistance programs. ## About This Program The Abbott Patient Assistance Foundation provided Abbott medications at no cost to people experiencing financial difficulty who could not afford their prescriptions. While Simcor is no longer manufactured, understanding how Abbott's program worked can help you navigate similar assistance programs for alternative medications. ## Who Qualifies for Abbott Patient Assistance To be eligible for Abbott's patient assistance program, patients typically needed to meet these criteria: - Be a resident of the United States - Have a valid prescription from a U.S.-licensed healthcare provider - Experience financial difficulty and meet Abbott's income guidelines based on Federal Poverty Guidelines adjusted for household size - Have no health insurance or inadequate prescription coverage for the requested medication - Not have access to alternative sources of coverage or funding Medicare Part D enrollees were considered on a case-by-case basis, and the program was considered the payer of last resort, meaning patients needed to demonstrate they could not access coverage through other means. ## Income Eligibility Abbott's program based eligibility on current Federal Poverty Guidelines adjusted for household size. Specific income thresholds for Simcor are not available in current program documentation, as the medication has been discontinued. However, Abbott's general approach considered household income relative to federal poverty levels. If you need assistance with a current medication, contact the manufacturer's patient assistance program directly to learn their specific income limits for your household size. ## Insurance Requirements The Abbott program required that applicants either: - Have no health insurance coverage - Have inadequate prescription coverage that would not pay for the requested medication - Be Medicare Part D enrollees (reviewed case-by-case) The program would not provide assistance if you had adequate coverage through private insurance, Medicaid, Medicare, or ADAP (AIDS Drug Assistance Program). ## How to Apply (Historical Process) The application process for Abbott's program involved these steps: **Step 1: Obtain an Application** Applications could be downloaded from Abbott's website or obtained by contacting the program directly at 1-(800) 222-6885. **Step 2: Complete the Application** Patients or their healthcare providers completed the application form, providing: - Personal and household information - Financial documentation - Current insurance status - Prescription details - Healthcare provider certification **Step 3: Submit Documentation** Completed applications were mailed or faxed to: - Abbott Patient Assistance Program - PO Box 270 - Somerville, NJ 08876 - Fax: 1-(866) 898-1473 **Step 4: Await Eligibility Determination** Applications were reviewed on a case-by-case basis. Both the prescriber's office and applicant were notified of eligibility status. **Step 5: Receive Medication** Upon approval, a supply of medication was shipped to the prescriber's office for dispensing to the patient. ## Timeline and Delivery Specific processing timelines for Abbott's program were not published in available documentation. However, the general process involved: - Application review on a case-by-case basis - Notification to prescriber and patient of eligibility status - Medication shipment to prescriber's office (not directly to patient) - Prescriber responsibility for dispensing to patient For current programs, contact the manufacturer directly for estimated processing times. ## Refills and Reauthorization Under Abbott's program: - Prescribers or office staff were responsible for contacting Abbott 3 weeks before the patient needed additional medication - If the patient remained within their eligibility period, additional medication supplies were shipped to the prescriber's office - If outside the eligibility period, patients received a re-enrollment application - Assistance was temporary, and patients could be asked to reapply ## What to Do If Your Application Is Denied If you were denied assistance through Abbott's program, options included: - Requesting clarification on denial reasons - Reapplying if circumstances changed - Exploring other patient assistance programs for similar medications - Contacting your healthcare provider about lower-cost alternatives - Investigating state pharmaceutical assistance programs - Checking if you qualify for Medicaid or other government programs ## Finding Alternatives Since Simcor is discontinued, speak with your healthcare provider about: - Other combination medications for cholesterol and triglyceride management - Separate medications that might be available through patient assistance programs - Generic alternatives that may be more affordable - Other manufacturers' patient assistance programs Many pharmaceutical companies offer patient assistance programs similar to Abbott's. Your healthcare provider or a patient advocacy organization can help identify programs for your current medications. ## Important Disclaimer This guide provides historical information about Abbott's patient assistance program. Simcor has been discontinued and is no longer available through this program. Program details, eligibility requirements, and processes may have changed. Always verify current information directly with the manufacturer or a patient assistance program coordinator before applying. This information is not a guarantee of eligibility or assistance. Consult your healthcare provider about your specific situation and available treatment options.

Program information last verified: March 30, 2026